6th Edition of Cardiology World Conference
September 15-17, 2025 | London, UK
Cardiac Enzyme Levels
Cardiac enzymes are essential indicators in the assessment of heart health, providing valuable insights into cardiac conditions. These enzymes, including myoglobin, creatine kinase-MB (CK-MB), and aspartate aminotransferase (AST), serve as sensitive markers for myocardial damage. Elevated levels of these enzymes in the bloodstream can signal various cardiac issues, such as myocardial infarction or angina. Among them, CK-MB is particularly specific to heart muscle, aiding in the accurate diagnosis of heart-related disorders. The measurement and interpretation of cardiac enzyme levels empower healthcare professionals to make informed decisions, facilitating early detection and intervention in cardiac emergencies. Understanding the nuances of different cardiac enzymes enhances the precision of cardiovascular diagnostics, contributing to more effective patient care.
Yong Xiao Wang
Albany Medical Center, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Gustavo Lionel Knop
Mayo Clinic, United States
Arthur J Siegel
Massachusetts General Hospital, United States
Abraham Teddy Weiss
Hadassah University Hospital, Israel
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Iris Panagiota Efthymiou
University of Greenwich, United KingdomSubmit your abstract Today
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : Empathy and precision: Revolutionizing communication between cardiologists and patients
Iris Panagiota Efthymiou, University of Greenwich, United Kingdom
Title : Ex-situ organ perfusion and cardiac performance improvement
Y J H J Taverne, Erasmus University Medical Center, Netherlands
Title : Subclinical atherosclerosis: Association with additional risk factors and somatic diseases
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : The past, present and future of AI in cardiology
Narendra Kumar, HeartbeatsZ Academy, United Kingdom